Real-world data from a single site showed long-lasting (mean duration of therapy 23.69 ± 11.18 months) resolution of the radiologic features of liver steatosis in 8 out of 11 patients, which was accompanied by a significant ALT reduction (21.83 ± 11.89 vs. 17.69 ± 8.00 IU/L; p = 0.042) [106]. This evidence concerns the gene GPT and Hepatic steatosis.